Hamilton Lane (NASDAQ:HLNE) has been the subject of 4 analyst reviews over the last three months, all indicating an 'Indifferent' stance. Despite this, price targets have been raised, with the current average target at $111.25, reflecting a 10.7% increase from the previous $100.50. The company faces challenges with a -17.28% revenue decline as of September 30, 2023, but shows financial strength with a high net margin of 33.1%, ROE of 9.36%, and ROA of 3.28%. Its debt-to-equity ratio is well-managed at 0.6.